
MicroStrategy (MSTR) currently holds a highly bullish Average Brokerage Recommendation (ABR) of 1.38, with 11 of 13 firms issuing 'Strong Buy' ratings. However, the article cautions against relying solely on ABRs, asserting they often exhibit a strong positive bias due to brokerage firms' vested interests and have limited success in predicting stock appreciation. It instead advocates for the proprietary Zacks Rank, a quantitative model driven by earnings estimate revisions, as a more reliable indicator. Despite MSTR's strong ABR, its unchanged current-year consensus earnings estimate of -$15.73 has resulted in a Zacks Rank #3 (Hold), suggesting the stock may perform in line with the broader market and warrants a cautious investment approach.
MicroStrategy (MSTR) presents a conflicting outlook based on a divergence between traditional analyst ratings and quantitative, earnings-based metrics. On one hand, Wall Street sentiment is exceptionally bullish, with an Average Brokerage Recommendation (ABR) of 1.38 on a 1-to-5 scale, where 11 of 13 covering firms rate the stock a 'Strong Buy'. On the other hand, this optimism is not reflected in the company's earnings estimate trends. The Zacks Consensus Estimate for the current year has remained stagnant over the past month at a loss of $15.73 per share. This lack of upward revision is the primary driver behind the stock's Zacks Rank #3 (Hold), which suggests its near-term performance is likely to align with the broader market rather than outperform. The analysis posits that while sell-side brokerage recommendations can be influenced by positive bias, near-term stock movements are more strongly correlated with trends in earnings estimate revisions, flagging the bullish ABR as potentially less reliable than the neutral signal from the stagnant earnings outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.20
Ticker Sentiment